Vallhala
Vallhala
Vallhala, New York, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-09-11 | NCT04972942 | |
| Defibrotide Dose-escalation for SOS Post-HSCT | Digestive System Diseases, cardiovascular disorder, hepatic veno-occlusive disease, liver disorder, vascular disorder | Recruiting | Phase 2 | 2026-04-15 | NCT05987124 | |
| Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunity, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-04-15 | NCT04197596 | |
| Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 2 | 2025-06-13 | NCT05253495 |